Inflammatory myofibroblastic tumour

Inflammatory Myofibroblastic Tumor (IMT) is a rare tumor that can occur in several parts of the body. It is characterized by a proliferation of myofibroblasts and inflammatory cells, including plasma cells, lymphocytes, and eosinophils. Although it can appear at any age, it is most commonly diagnosed in children and young adults. The etiology of IMT is not fully understood, but it is believed to involve a combination of genetic, immunologic, and infectious factors.

Symptoms and Diagnosis

The symptoms of an Inflammatory Myofibroblastic Tumor vary depending on its location in the body but can include pain, swelling, and a palpable mass. In some cases, IMT can cause systemic symptoms such as fever, weight loss, and malaise. Diagnosis typically involves imaging studies such as CT scans or Magnetic Resonance Imaging (MRI), followed by a biopsy to confirm the presence of myofibroblastic and inflammatory cells.

Treatment

Treatment options for IMT include surgical resection, which is often the preferred method to remove the tumor completely. In cases where surgery is not feasible, or the tumor is not completely resectable, other treatments such as corticosteroids, chemotherapy, and radiation therapy may be considered. Recently, targeted therapies have shown promise in treating IMT, particularly in cases with specific genetic alterations such as ALK (anaplastic lymphoma kinase) rearrangements.

Prognosis

The prognosis for patients with Inflammatory Myofibroblastic Tumor is generally favorable, especially when complete surgical resection is possible. However, the tumor has a tendency to recur, and long-term follow-up is necessary. The presence of certain genetic alterations, such as ALK rearrangements, can influence the prognosis and response to therapy.

Epidemiology

Inflammatory Myofibroblastic Tumor is considered a rare entity, with a variable incidence reported in the literature. It can occur at any age but has a peak incidence in children and young adults. There is no clear gender predilection.

Pathophysiology

The pathogenesis of IMT is not fully understood, but it is thought to involve a combination of genetic, immunologic, and possibly infectious factors. Genetic alterations, such as rearrangements involving the ALK gene, have been identified in a subset of IMTs and are thought to play a role in the pathogenesis of these tumors.

Histopathology

Histologically, IMT is characterized by a mixture of spindle-shaped myofibroblasts and a variable inflammatory infiltrate composed of plasma cells, lymphocytes, and eosinophils. The myofibroblastic cells typically exhibit a pattern of proliferation without significant atypia or mitotic activity.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian